ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1332

Identifying the as Patient at Risk: Is Aortic Root Diameter Associated with HLA-B27?

Milad Baniaamam1, Sjoerd C. Heslinga2, M. Louis Handoko3, Thelma C. Konings3, Otto Kamp3, Vokko P. van Halm4, J. Christiaan van Denderen1, Irene van der Horst-Bruinsma2 and Mike Nurmohamed5, 1Reade, Amsterdam, Netherlands, 2Department of Rheumatology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, Netherlands, 3Department of Cardiology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, Netherlands, 4Department of Cardiology, Amsterdam UMC, location VU University Medical Centre, Amsterdam, 5Amsterdam Rheumatology and immunology Center, location Reade and Amsterdam UMC, VU medical center, Amsterdam, Netherlands

Meeting: ACR Convergence 2020

Keywords: Ankylosing spondylitis (AS), Cardiovascular, immunology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Extra-MSK & Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ankylosing spondylitis (AS) is an inflammatory joint disease (IJD) associated with cardiac involvement particularly aortic valve regurgitation (AVR).  AVR in AS is caused by inflammation of the aortic root and valves. Furthermore, HLA-B27 genotype is strongly associated with AS and with cardiac diseases in non-rheumatic patients. Therefore, the question arises whether HLA-B27 genotype results in an increased risk of developing AVR and aortic root dilatation in AS patients. In this study, we investigated the association between the aortic root diameter in HLA-B27 positive (+) versus HLA-B27 negative (-) patients in AS patients from the CARDAS cohort.

Methods: The CARDAS study is a cross-sectional study in AS patients between 50-75 years who were recruited from a large rheumatology outpatient clinic. Patients underwent cardiovascular screening including echocardiography, with 2D, spectral and colour flow Doppler. The aortic root was measured at sinuses of Valsalva during diastole. The aortic root diameter was corrected for body surface area (BSA) (aortic root index, cm/ m²).

Results: 193 Consecutive AS patients were included of whom 158 (82%) HLA-B27 positive. HLA-B27+ and HLA-B27- AS subjects had a comparable disease duration, respectively 36 (±11) and 30 (±14) years, and a moderate disease activity assessed with the ASDAS-CRP, respectively 2.1 (±1.0) and (2.3 ±1.0).  The aortic root index was higher in HLA-B27+ patients compared to HLA-B27- patients, respectively 1.76 ± 0.21 mm vs. 1.64 ± 0.14 mm, p< 0.001. Furthermore, HLA-B27+ AS patients compared to HLA B27- AS patients had more often aortic root dilatation (≥2.1 cm/m²), respectively 11 (8%) and 1 (3%), p=0.3 (table 1). The presence of aortic root dilatation in HLA-B27+ AS patients was strongly associated with aortic valve regurgitation, p=0.003.  Regression analysis showed a significant association between HLA-B27 and aortic root index corrected for age, sex and cardiovascular risk factors, B 0.091 (95%CI 0.015-0.168), p=0.02. Furthermore, male HLA-B27+ patients had a significant increased aortic root index compared to male HLA-B27- AS patients, respectively 1.76 (1.63-1.88) and 1.59 (1.53-1.68), p< 0.001.

Conclusion: In conclusion, our study demonstrates an increased aortic root index in elderly HLA-B27+ AS patients, specifically in male patients. Although, this did not result in an increased prevalence of aortic valve regurgitation in this subgroup, inflammation of the aortic root and valve in chronic inflammatory disease is progressive and may progress to severe complications. Therefore, to identify  AS patients patient at risk for cardiac disease, we recommend echocardiographic monitoring in elderly male HLA-B27+ AS. Future studies should assess cost effectiveness of cardiologic screening in this subgroup.


Disclosure: M. Baniaamam, None; S. Heslinga, None; M. Handoko, None; T. Konings, None; O. Kamp, None; V. van Halm, None; J. van Denderen, None; I. van der Horst-Bruinsma, AbbVie, 1, 2, 3, UCB Pharma, 2, 5, 8, Merck Sharp & Dohme, 1, 2, 3, Novartis, 1, Pfizer, 1, 2, Bristol-Myers Squibb, 1; M. Nurmohamed, None.

To cite this abstract in AMA style:

Baniaamam M, Heslinga S, Handoko M, Konings T, Kamp O, van Halm V, van Denderen J, van der Horst-Bruinsma I, Nurmohamed M. Identifying the as Patient at Risk: Is Aortic Root Diameter Associated with HLA-B27? [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/identifying-the-as-patient-at-risk-is-aortic-root-diameter-associated-with-hla-b27/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-the-as-patient-at-risk-is-aortic-root-diameter-associated-with-hla-b27/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology